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LETTER
Suilysin remodels the cytoskeletons of
human brain microvascular endothelial cells
by activating RhoA and Rac1 GTPase
Dear Editor,
Streptococcus suis (S. suis) is a Gram-positive, facultative
anaerobic coccus and an important emerging pathogen. It is
associated with bacterial meningitis in adults, especially in
southeastern Asia (Wertheim et al., 2009). A striking feature
of S. suis infection is the resulting complications, which may
include deafness and vestibular dysfunction. Complications
of some kind affect 50% of S. suis patients in Europe and
73% of those in Asia (Gottschalk et al., 2010). Some S. suis
surface-associated factors, such as the capsule and Fhb,
may affect the pathogenesis of meningitis. Of these secreted
factors, suilysin was found to be the most important. It has
been found to be toxic to various types of cells (Lalonde
et al., 2000). It is also involved in modulation of the inter-
actions of S. suis with different host cells (Charland et al.,
2000; Segura et al., 2006). Epidemic S. suis ST7 strains
were found to produce more suilysin than other ST strains
(unpublished data). This has been shown to contribute to
their ability to travel across the epithelial barrier, which they
do in a TLR4-dependent manner. This ability is also asso-
ciated with the increased severity of S. suis infection
(unpublished data). Recently, subcytolytic suilysin was
shown to promote S. suis association with epithelial cells
without causing the formation of functional (cytolytic) pores.
This indicated that sublytic concentrations of suilysin also
contributed to pathogenesis by modiﬁcation of host-patho-
gen interactions (Seitz et al., 2013). However, the mecha-
nism underlying suilysin-mediated modulation of microbial-
host interactions has not yet been fully explained.
In the present study, human brain microvascular endo-
thelial cells (hBMECs) were treated with non-cytotoxic and
sublytic concentrations of the culture supernatant of S. suis
serotype 2 strain 05ZYH33 and stained with FITC-labeled
phalloidin at different time points after challenging the culture
with sublytic supernatant. Fluorescence microscopy showed
stress ﬁbers, lamellipodia, and ﬁlopodia to be visible 5–
40 min after treatment (Fig. S1). These results demonstrated
that sublytic concentrations of S. suis culture supernatant
rearranged the cytoskeletons of the hBMECs. Suilysin has
been shown to be the most important virulence factor in the
secreted supernatant of S. suis. Suilysin is presumed to be
the effective component of S. suis culture supernatant, and
the factor primarily responsible for the remodeling of hBMEC
cytoskeletons. To conﬁrm this, hBMEC cells were treated with
sublytic concentrations of suilysin protein (0.3 μg/mL) puriﬁed
from S. suis cell culture supernatant over different periods of
time. As shown in Fig. 1, suilysin led to the rapid formation of
ﬁlopodia, stress ﬁbers, and lamellipodia in hBMECs. Lipids
and cholesterol have been identiﬁed as the receptors of su-
ilysin, as well as some cholesterol-dependent cytolysins
(CDCs). To conﬁrm the cholesterol dependence of the effects
of suilysin, suilysin was exposed to cholesterol at mass ratios
of 1:1 and 1:5 for 15 min at 37°C immediately before it was
applied to the hBMEC cells for 10 min. As shown in Fig. 1,
pretreatment of suilysin with cholesterol at a 1:1 ratio reduced
the formation of lamellipodia and ﬁlopodia, although actin
stress ﬁbers still formed. When suilysin was pretreated with
cholesterol at a 5:1 cholesterol:suilysin ratio, the suilysin-
induced changes in actin were completely absent. The
changes in actin were also absent when cellular cholesterol
was removed using 2 mmol/L methyl-β-cyclodextrin (MβCD)
to inhibit suilysin binding. Taken together, these results indi-
cate that the changes in actin cytoskeleton organization
induced by suilysin were cholesterol-dependent.
Generally, Rho-subclass GTPases produce stress ﬁbers,
Rac produces ﬁlopodia and lamellipodia, and Cdc42 pro-
duces ﬁlopodia (Tapon and Hall, 1997). To conﬁrm the
effects of suilysin on these pathways, RhoA-associated
kinase (ROCK) inhibitor Y27632 was used to pretreat
hBMECs for 1 h before suilysin challenge. The inhibitor
Y27632 prevented the formation of stress ﬁbers after 10 min
of suilysin treatment (Fig. 1). However, RhoA, which is
upstream of ROCK in the signaling pathway, was still acti-
vated (Fig. 2E). These results indicated that the changes in
actin cytoskeleton organization induced by suilysin were
GTPase-dependent. Next, the molecular basis of the chan-
ges in actin induced by S. suis culture supernatant was
assessed. A rhotekin-based pull-down assay showed
approximately 3-fold activation of RhoA 5 min after treatment
by sublytic concentration of S. suis culture supernatant,
which peaked at 10 min and was found to have returned to
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resting levels at 30 min (Fig. 2A). A p21-activated, kinase-
based pull-down assay showed that Rac1 peaked at 10 min,
and its activation showed a downward trend that remained
constant for 20 min (Fig. 2B). Then, the activation of RhoA
and Rac1 in hBMECs after suilysin treatment was assessed.
A rhotekin-based pull-down assay showed RhoA to be
activated from 10 min to 30 min after suilysin treatment, after
which it decreased, reaching resting levels by 45 min
(Fig. 2C). A p21-activated kinase-based pull-down assay
showed that Rac1 was activated at 10 min after suilysin
treatment and peaked at 20 min (Fig. 2D). Taken together,
these results suggest that S. suis culture supernatant and
suilysin protein can activate RhoA and Rac1 in a time-
dependent fashion, but their activation effects peak at dif-
ferent times.
Because the suilysin-induced changes in the organization
of the actin cytoskeleton were found to be cholesterol-
dependent, the issue of whether the suilysin-induced activa-
tion of RhoA is also cholesterol-dependent was addressed.
Suilysin was pretreated with cholesterol at mass ratios of 1:1
and 1:5 for 15 min at 37°C. Then, the hBMEC cells were
treated with this suilysin-cholesterol mixture for 10 min. As
shown in Fig. 2E, suilysin pretreated with cholesterol at a 1:1
ratio still activated RhoA. When suilysin was pretreated with
cholesterol at a 5:1 cholesterol: suilysin ratio, the activation of
RhoA induced by suilysin was completely inhibited. Previous
studies have shown that hemolysin-positive S. suis strains
used adherence and suilysin-induced BMEC injury to move
from the circulatory system to the central nervous system
(Charland et al., 2000). This indicates that hemolytic activity is
the basis for suilysin activity. However, in the present work,
sublytic concentrationsof suilysinwere found toactivateRhoA
and Rac1, causing remodeling of the actin cytoskeleton. This
indicated that suilysin might have functions independent of
hemolytic activity. To further analyze the correlation between
the GTPase activation induced by suilysin and the hemolytic
activity of suilysin, a recombinant suilysin mutant, SLY
(P353L), which was proven to lack hemolytic ability, was
constructed (Xu et al., 2010). Different concentrations of
puriﬁed SLY (P353L) protein were used to treat hBMECs for
10 min, and active GTPases were analyzed using pull-down
assays. As shown in Fig. 2F, SLY (P353L), cannot activate
RhoA, but can activate Rac1 at relatively low concentrations
(0.27 μg/mL). These results suggested that the ability of
suilysin to activate Rac1 was independent of its hemolytic
activity.
Pathogenic microbes subvert normal host cell processes
to create a specialized niche, facilitating their survival.
Pathogens often target the cytoskeleton of the host cell,
which they use for attachment, entry into cells, movement
within and between cells, vacuole formation and remodeling,
and avoidance of pathocytosis (Barbieri et al., 2002; Rottner
et al., 2005). In this work, non-cytotoxic and sublytic con-
centrations of S. suis suilysin were found to remodel the
actin cytoskeleton. These results contribute to understand-
ing of the manner by which S. suis traverses the human
blood-brain barrier (BBB). Recent studies also have shown
that microbial translocation of the BBB involves host cell
actin cytoskeletal rearrangements (Kim, 2006). For example,
human BMEC actin cytoskeleton rearrangements were
Control SLY  1 min SLY  3 min SLY  6 min SLY  12 min
chol:SLY (1:1) Chol:SLY (5:1) SLY Y2763 SLY M CDSLY 10 min
Figure 1. Suilysin-induced changes in the organization of the actin cytoskeleton were dependent on the concentrations of
cholesterol and GTPase. hBMEC cells were treated with sublytic concentrations of suilysin protein for indicated periods after
pretreatment regimens. Actin ﬁlaments were stained with FITC-labeled phalloidin. Chol: cholesterol. Y27632: ROCK inhibitor. MβCD:
cellular cholesterol depletion.
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shown to be a prerequisite for human BMEC invasion by
E. coli K1, group B streptococcus, and L. monocytogenes
(Kim, 2006). In addition to invasion, some pathogens, such
as Neisseria meningococcus, induce changes in the host
cell cytoskeleton, recruiting endothelial cell adhesion mole-
cules such as VE-cadherin to cortical plaques. This recruit-
ment leads to the formation of ectopic intercellular junctional
domains at the site of bacteria-host cell interaction, depletion
of junctional proteins at the cell-cell interface, opening of
intercellular junctions, and crossing the BBB in a paracellular
manner (Coureuil et al., 2009; Coureuil et al., 2010). For this
reason, actin rearrangement induced by suilysin might initi-
ate the paracellular traversal of S. suis across the human
BBB.
Several signal transduction pathways have been shown
to be involved in rearranging the actin cytoskeleton. These
include the FAK, PI3K, Src kinase, and Rho GTPase path-
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Figure 2. Suilysin-induced activation of GTPases in hBMECs was dependent on the concentration of cholesterol but not
hemolytic activity. hBMEC cells were serum-starved and then treated with (A and B) S. suis supernatant or (C and D) suilysin
protein at sublytic concentrations for indicated periods. (E) hBMEC cells pretreated with Y27632 or left untreated were then treated
with suilysin that had been pretreated with cholesterol or left untreated. (F) hBMEC cells were treated with P353L mutant of suilysin at
indicated concentrations. (A, C, E and F) RhoA and (B, D and F) Rac1 activation was detected using pull-down and Western blot
assays with total RhoA and Rac1 amounts at each point in time as shown in the images of the endogenous control and representative
samples. (C and D) Relative amounts of activated RhoA and Rac1 from three independent experiments with mean ± SEM (bottom
panel).
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is the only known pore-forming toxin that uses the small
GTPases found in intact cells to alter the actin cytoskeleton
(Iliev et al., 2007; Hupp et al., 2013). The present results
demonstrate another case, showing that actin cytoskeleton
rearrangment is a novel function of suilysin. These ﬁndings
contribute to the current understanding of the mechanism by
which S. suis traverses the human BBB, suggesting new
potential targets for the treatment of meningitis.
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